In the present study, too, cases with predominant expression of POU2F3 or NEUROD1 showed a trend towards inferior relapse-free survival; however, sample size was small ( n = 3) and correlations did not remain significant following correction for clinical parameters (Extended Data Fig. 7a–d and Supplementary Table 10 ).
1
—
—